CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13,917 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03484806
NCT03484806N/ACompleted

China Registry and Cohort Study of Valvular Heart Disease in Adults

China National Center for Cardiovascular Diseases·observational·Posted Apr 2, 2018·Updated Apr 13, 2022

In Brief

An observational study for Valvular Heart Disease. Completed, enrolled 13,917 participants across 1 site.

Detailed Summary

This is a observational、multicenter, prospective cohort study for adults with significant VHD. The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with VHD;also to set up registration system of adult VHD in China, to build a database of Chinese adult VHD, to establish a web-based international standard data acquisition system for VHD and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of adult VHD.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2, 2018
Enrollment StartApr 1, 2018
Primary CompletionSep 1, 2020
Study CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 8.3 years ago